Skip to search form
Skip to main content
Semantic Scholar's Logo
Create Free Account
You are currently offline. Some features of the site may not work correctly.
BIII 890 CL
National Institutes of Health
Semantic Scholar uses AI to extract papers important to this topic.
BIII-890-CL. Boehringer Ingelheim.
Current opinion in investigational drugs
Corpus ID: 2158593
BIII-890-CL is a non-orally active sodium channel blocker under development by Boehringer Ingelheim Corp for the potential…
Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL.
A. J. Carter
Proceedings of the National Academy of Sciences…
Corpus ID: 42877285
We have synthesized a new benzomorphan derivative, 2R-[2alpha,3(S*), 6alpha]-1,2,3,4,5,6-hexahydro-6,11, 11-trimethyl-3-[2…
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Terms of Service
ACCEPT & CONTINUE